U.S. Cancer Treatment Market - Industry Trends and Forecast to 2029

Market Definition:

Cancer is a disease in which some of the body's cells grow uncontrollably and eventually spread to other parts of the body. The cancerous tumor spreads to nearby tissues and can travel to distant places within the body to form a new tumor. This process is called metastases. The cancerous tumor is also referred to as a malignant tumor. The benign tumor does not invade nearby tissues, and when removed, benign tumors usually don't grow back, whereas cancerous tumors sometimes do.

There are more than a hundred types of cancer. Some cancers that begin in specific types of cells include carcinoma, sarcoma, leukemia, lymphoma, and multiple myeloma, among others. Many types of cancer are available based on the type of cancer treatments. Cancer treatment includes biomarker testing, chemotherapy, hormone therapy, hyperthermia, immunotherapy, photodynamic therapy, radiation therapy, surgery, stem cell transplant, and targeted therapies.

According to GLOBOCAN, 19,292,789 new cancer cases were found in 2020 worldwide. The highest cases of breast cancer were found. Therefore, the high prevalence of cancer, initiatives taken by the government for awareness and early detection of cancer, and ongoing clinical trials are expected to fuel the market's growth.

Market Segmentation:

The U.S. cancer treatment market is categorized into four notable segments based on cancer type, treatment, route of administration, and end user.

• On the basis of cancer type, the U.S. cancer treatment market is segmented into breast cancer, colorectal cancer with liver metastases, lung carcinoma, prostate cancer, ovarian cancer, head-and-neck cancer, pancreatic cancer, glioblastoma, renal cell carcinoma, anaplastic thyroid carcinoma, and sarcoma

• On the basis of treatment, the U.S. cancer treatment market is segmented into medication, targeted therapies, radiotherapy, surgery, and others

• On the basis of route of administration, the U.S. cancer treatment market is segmented into injectable, oral, and others

• On the basis of end user, the U.S. cancer treatment market is segmented into hospitals and specialty clinics

Market Players

Some of the major companies dealing in the U.S. cancer treatment market are listed below:

• Bristol-Myers Squibb Company
• F. Hoffman La-Roche Ltd.
• Clegen
• AbbVie, Inc.
• Pfizer, Inc.
• Novartis AG